Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
The American Journal of Managed Care|June 15, 2012
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndromeGrace Wang, Miriam Kuppermann, Benjamin Kim, et al.
Clinical Transplantation|February 17, 2010
Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantationUri Ladabaum, Shan L Cheng, Francis Y Yao, et al.
Gastrointestinal Endoscopy|July 16, 2013
Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging?Sheila Kumar, Ann Fioritto, Aya Mitani, et al.
Cancer|May 25, 2016
Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment toolUri Ladabaum, Ashley Patel, Ajitha Mannalithara, et al.
Gastroenterology|February 12, 2021
Colorectal Cancer Incidence After Colonoscopy at Ages 45-49 or 50-54 YearsMaanek Sehgal, Uri Ladabaum, Alka Mithal, et al.
The American Journal of Gastroenterology|July 2, 2014
Colorectal testing utilization and payments in a large cohort of commercially insured US adultsUri Ladabaum, Zachary Levin, Ajitha Mannalithara, et al.
The American Journal of Gastroenterology|October 3, 2020
Randomized Controlled Trial of Personalized Colorectal Cancer Risk Assessment vs Education to Promote Screening UptakeTimothy Yen, FeiFei Qin, Vandana Sundaram, et al.
The American Journal of Gastroenterology|June 16, 2018
Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. MedicareUri Ladabaum, Ajitha Mannalithara, Joel V Brill, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 13, 2005
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosisDerek Patel, Norah A Terrault, Francis Y Yao, et al.
Stem Cell Research|May 5, 2026
Generation of two induced pluripotent stem cell lines from patients carrying heterozygous PTEN mutations associated with PTEN Hamartoma Tumor SyndromeKristina Zdantsevich, Renke Tan, Dong Li, et al.
Pageof 27